1 / 4

Cell Therapy Manufacturing Market to Exhibit Steadfast Growth During 2018-2026 Forecast by Global Top Players

Cell therapy is one of the most promising healthcare procedure for restoration of damaged tissue.<br>

rushi12
Download Presentation

Cell Therapy Manufacturing Market to Exhibit Steadfast Growth During 2018-2026 Forecast by Global Top Players

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cell Therapy Manufacturing Market - Size, Cell Therapy Manufacturing Market - Size, Share, Growth, Outlook, and Opportunity Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Analysis, 2018-2026 Cell therapy is one of the most promising healthcare procedure for restoration of damaged tissue. Cell therapies have huge potential for the wide range of disease treatment including tissue degradation, immune deficiency, metabolic disorders, and cancer. Cell therapy are categorized into two type’s allogeneic (cells from third party donor) and autologous (cells from one’s own body). Cell therapy has gained significant traction in recent past and currently it under commercial development. Main objective of cell therapy is to re-establish the lost function of tissues and cells rather than to produce a new organ. Some cell therapies have been established and permitted for clinical trial. For instance, in 2013 a stage 2 clinical trial was completed for transplantation of bone marrow derived stem cells in affected knee by rheumatoid arthritis. The growth of this technique is also increased due to involvement of the government agencies. For instance, innovate U.K. 2014 report showed that government agreed to fund US$15.3 million in cell therapy manufacturing market. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1728 Cell Therapy Manufacturing Market Dynamics Increasing number of surgical procedures performed across the world coupled with increasing number of trauma and accidents is propelling demand for new medical therapy. For instance, according to a 2015, World Health Organization (WHO) report, more than 50,000 stem cell transplants are carried out annually worldwide for various surgeries. Cell Therapy Manufacturing Market - Regional Insights On the basis of the region, the global cell therapy market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global cell therapy manufacturing market, owing to large number of surgeries performed in the

  2. region as well as development of technologically advanced products for therapy. According to the National Health Statistics Report by the Centers for Disease Control & Prevention (CDC), around 201,748.3 million surgical and non-surgical procedures were performed in the U.S. in 2011. Furthermore, Asia Pacific is projected to witness significant growth in the global cell therapy manufacturing market in the near future. Marginal market share would be grabbed by the local players entering into market due to less stringent regulatory requirements and growing customer pool prone to various chronic and infectious disease such as cancer, HIV, hepatitis etc. Therefore induction of cell therapy can provide better solutions to the patient at the marginally lower cost. Report includes chapters which deeply display the following deliverable about industry : • Cell Therapy Manufacturing Market Research Objective and Assumption • Cell Therapy Manufacturing Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Cell Therapy Manufacturing Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Cell Therapy Manufacturing Market, By Regions • Cell Therapy Manufacturing Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Cell Therapy Manufacturing Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Cell Therapy Manufacturing Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Cell Therapy Manufacturing Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Pharmicell, Merck Group, Dickinson and Company, Thermo Fisher, Lonza Group, Miltenyi Biotec GmBH, Takara Bio Group, STEMCELL Technologies, Cellular Dynamics International, Becton, Osiris Therapeutics, Bio-Rad Laboratories, Inc., Anterogen, MEDIPOST, Holostem Terapie Avanazate, Pluristem Therapeutics, Brammer Bio, CELLforCURE, Gene Therapy

  3. Catapult EUFETS, MaSTherCell, PharmaCell, Cognate BioServices and WuXi AppTec. Key players are adoption growth strategies such as collaborations, introduction of new technologies and devices to maintain dominant position in the market. For instance, in 2014, ViaCyte, Inc. successfully implanted VC-01 an embryonic stem cell derived islet for the treatment of type 1 diabetes. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1728 Cell Therapy Manufacturing Market Taxonomy On the basis of therapy type, the global cell therapy manufacturing market is segmented into: • Allogeneic Cell Therapy • Autologous Cell Therapy On the basis of technology, the global cell therapy manufacturing market is segmented into: • Somatic Cell Technology • Cell Immortalization Technology • Viral Vector Technology • Genome Editing Technology • Cell Plasticity Technology • 3D Technology On the basis of source, the global cell therapy manufacturing market is segmented into: • IPSC’s (Induced pluripotent stem cell) • Bone marrow • Umbilical cord • Adipose tissue • Neural stem On the basis of application, the global cell therapy manufacturing market is segmented into: • Musculoskeletal • Cardiovascular • Gastrointestinal • Neurological • Oncology • Dermatology

  4. • Others On the basis of region, the global cell therapy manufacturing market is segmented into: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action- ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related